Drug Trial Radar · NCT01750190
A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis
Last checked: Nov 19, 2026Latest source record: Oct 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
922
Actual
Start
Nov 5, 2012
Primary completion
Sep 24, 2018
Study completion Sep 24, 2018
Sponsor
- Lead sponsor
- Kyntra BioIndustry
- Sponsor type
- Industry
- Collaborators
- Astellas Pharma Europe B.V.; AstraZeneca
- First posted
- Dec 17, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether roxadustat is safe and effective in the treatment of anemia in participants with chronic kidney disease and not on dialysis.
Conditions
- CKD Anemia
Interventions
RoxadustatDrug
Oral tablets
PlaceboDrug
Oral tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- United States (US FDA) Submission: Mean Change From Baseline in Hb (g/dL) Over Weeks 28 to 52 Regardless of Rescue TherapyTime frame: Baseline (Day 1, Week 0), Weeks 28 to 52
- Ex-US Submission: Number (%) of Participants Who Achieved a Hb Response During the First 24-Weeks of Treatment Censoring for Rescue TherapyTime frame: Baseline up to Week 24
Locations
145 sites in 16 countries. Site status is shown where the registry gives one.
Investigational Site
Huntsville, Alabama
Investigational Site
Tempe, Arizona
Investigational Site
Alhambra, California
Investigational Site
Chula Vista, California
Investigational Site
Inglewood, California
Investigational Site
La Mesa, California
Investigational Site
La Palma, California
Investigational Site
Lynwood, California
Investigational Site
Northridge, California
Investigational Site
Paramount, California
Investigational Site
Riverside, California
Investigational Site
Roseville, California
Investigational Site
San Dimas, California
Investigational Site
Whittier, California
Investigational Site
Coral Gables, Florida
Investigational Site
Cutler Bay, Florida
Investigational Site
Hialeah, Florida
Investigational Site
Miami, Florida
Investigational Site
Miami, Florida
Investigational Site
Miami, Florida
Investigational Site
Miami, Florida
Investigational Site
Ocala, Florida
Investigational Site
Pembroke Pines, Florida
Investigational Site
South Miami, Florida
Investigational Site
Winter Park, Florida
Investigational Site
Augusta, Georgia
Investigational Site
Caldwell, Idaho
Investigational Site
Shreveport, Louisiana
Investigational Site
Baltimore, Maryland
Investigational Site
Boston, Massachusetts
Investigational Site
Detroit, Michigan
Investigational Site
Flint, Michigan
Investigational Site
Flint, Michigan
Investigational Site
Pontiac, Michigan
Investigational Site
Roseville, Michigan
Investigational Site
St Louis, Missouri
Investigational Site
New Brunswick, New Jersey
Investigational Site
Albuquerque, New Mexico
Investigational Site
Mineola, New York
Investigational Site
The Bronx, New York
Showing 40 of 145 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.